Jeremy Levin
Follow
Get notifications in MyBN when activity occurs.
Jeremy Levin
Non-Executive Chair / Opthea
Dr Jeremy Levin has been the chair and chief executive of Ovid Therapeutics, a biopharmaceutical company.
He holds a Bachelor of Arts in Zoology, a Master of Arts in Cell Biology, and a Doctor of Philosphy in Chromatin Structure - all from University of Oxford. He also holds a Bachelor of Medicine and Bachelor of Surgery (BChir) from the University of Cambridge.
He holds a Bachelor of Arts in Zoology, a Master of Arts in Cell Biology, and a Doctor of Philosphy in Chromatin Structure - all from University of Oxford. He also holds a Bachelor of Medicine and Bachelor of Surgery (BChir) from the University of Cambridge.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1002nd | Opthea | -19% | -2% |
| 1113th | QuickFee | -26% | |
| 1329th | Zoono Group | -41% | -13% |
| 1370th | 8Common | -43% | 3% |
| 1809th | Galilee Energy | -76% | -39% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 700th |  | Opthea | $19.1m |
| 816th | | Galilee Energy | $7.8m |
| 817th | | Zoono Group | $7.8m |
| 819th | | QuickFee | $7.6m |
| 821st | | 8Common | $7.5m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Chair, Opthea | 03 Nov 2020 |
